- Report
- February 2024
- 150 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- February 2023
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
Zithromax is a brand of the antibiotic azithromycin, which is used to treat a variety of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Zithromax is commonly prescribed for respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Zithromax is available in both oral and intravenous forms, and is generally well-tolerated with few side effects.
The Zithromax market is a subset of the larger antibiotics market, which is composed of a variety of drugs used to treat bacterial infections. Antibiotics are a critical component of modern medicine, and are used to treat a wide range of illnesses. The global antibiotics market is expected to grow in the coming years, driven by the increasing prevalence of bacterial infections and the development of new antibiotics.
Some of the major companies in the Zithromax market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more